K. Barton

发表

Transcription factor GATA-3 is required for development of the T-cell lineage

J. Leiden, C. Ting, M. Olson, 1996, Nature.

Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis.

S. Alkan, M. Ergin, H. Amin, 2001, British journal of haematology.

The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis.

C. T. Kuo, C. Clendenin, J. Leiden, 1997, Genes & development.

Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements

R. Sood, G. Nucifora, K. Barton, 1999, Leukemia.

Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma.

J. Friedberg, J. Winter, L. Rimsza, 2013, The New England journal of medicine.

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitions

Jiwang Zhang, K. Barton, P. Hagen, 2022, Blood Cancer Journal.

Chapter 1 – Chronic Myelogenous Leukemia: A Model for the Genetic and Biochemical Basis of Neoplasia

C. Westbrook, K. Barton, 1994 .

Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy.

M. Picken, D. Leehey, K. Barton, 2009, Archives of pathology & laboratory medicine.

When Monoclonal Gammopathy is of Renal Significance: A Case Study of Crystalglobulinemia From Chicago Multiple Myeloma Rounds.

P. Venugopal, P. Hari, R. Rodby, 2019, Clinical lymphoma, myeloma & leukemia.

Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysis

Sonali M. Smith, J. Friedberg, J. Winter, 2019, Leukemia & lymphoma.

Randomized phase III U.S./Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL).

J. Friedberg, J. Winter, R. Fisher, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all‐trans retinoic acid) therapy

S. Alkan, S. Nand, K. Barton, 2006, European journal of haematology.

Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area

P. Stiff, P. Rajakumar, Raymond Lee, 2020, Blood.

AML1 haploinsufficiency, gene dosage, and the predisposition to acute leukemia.

G. Nucifora, K. Barton, 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1.

L. Garrett-Sinha, M. Simon, S. Rao, 2001, Blood.

Defective activation and survival of T cells lacking the Ets-1 transcription factor

N. Muthusamy, J. Leiden, K. Barton, 1995, Nature.

Elf-1 PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or

L. Garrett-Sinha, M. Simon, Sridhar Rao, 2013 .

Clinical Characterization of Children Presenting to the Hospital with Enterovirus D68 Infection During the 2014 Outbreak in St. Louis

J. Baty, A. Padhye, K. Barton, 2016, The Pediatric infectious disease journal.

Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electrophoresis.

C. Westbrook, C. Rubin, K. Barton, 1989, Blood.

Azacitidine Plus Gemtuzumab Ozogamicin (GO): A Novel Combination in the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) in the Elderly.

Scott E. Smith, P. Stiff, S. Nand, 2006 .

Thrombotic microangiopathy associated with sunitinib, a VEGF inhibitor, in a patient with factor V Leiden mutation

M. Picken, D. Leehey, Joseph I. Clark, 2008, NDT plus.

by pulsed-field gel electrophoresis Detection of the Philadelphia chromosome in acute lymphoblastic leukemia

C. Westbrook, C. Rubin, K. Barton, 2011 .

The effects of the anti-tumor agent mezerein on the cytotoxic capacity and oxidative metabolism of human blood cells

A. Sagone, K. Barton, G. Randal, 1989, Investigational New Drugs.

Heckathorn disease revisited.

A. Kini, S. Nand, K. Barton, 2014, Blood.

Management of Scalp Toxic Epidermal Necrolysis and Cranial Osteomyelitis With Serratus Anterior Myocutaneous Pedicle Flap: A Case Report

R. Gamelli, V. Prabhu, M. Levitt, 2007, Journal of burn care & research : official publication of the American Burn Association.

Intracranial meningiomas in individuals under the age of 30; Analysis of risk factors, histopathology, and recurrence rate

V. Prabhu, Douglas E Anderson, E. Melian, 2014 .

Characterization of metal binding peptides from cadmium resistant plant cells.

P. Jackson, J. Trewhella, N. Robinson, 1987, Experientia. Supplementum.

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.

H. Avet-Loiseau, L. Coignet, S. Alkan, 2004, Blood.

The Ets-1 transcription factor is required for the development of natural killer cells in mice.

N Muthusamy, L. Lanier, T. Walunas, 1998, Immunity.

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty.

J. Leiden, M. Lu, E. Barr, 1995, The Journal of clinical investigation.

Transcriptional Regulation of CD1D1 by Ets Family Transcription Factors1

Chyung-Ru Wang, K. Barton, P. Laslo, 2005, The Journal of Immunology.

Expression of the IFNα receptor in hairy cell leukaemia

L. Platanias, L. Pfeffer, J. Vardiman, 1992 .

Analysis of expression of nuclear factor κB (NF‐κB) in multiple myeloma: downregulation of NF‐κB induces apoptosis

S. Alkan, M. Ergin, H. Amin, 2001 .

Microphthalmia due to p53-mediated apoptosis of anterior lens epithelial cells in mice lacking the CREB-2 transcription factor.

J. Leiden, T. Hettmann, K. Barton, 2000, Developmental biology.

Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB

C. Clendenin, N. Muthusamy, J. Leiden, 1996, Nature.

Clinical and Pathologic Issues in Patients with Amyloidosis: Practical Comments Regarding Diagnosis, Therapy, and Solid Organ Transplantation

M. Picken, K. Barton, J. Dalal, 2012 .

Recurrent strokes in two patients with POEMS syndrome and Castleman's disease.

J. Biller, S. Hocker, R. Dafer, 2007, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Value of Ki-67 Labeling Index in Predicting Recurrence of WHO Grade I Cranial Base Meningiomas

V. Prabhu, E. Melian, B. Martin, 2018, Journal of Neurological Surgery Part B: Skull Base.

Analysis of histone deacetylase inhibitor, depsipeptide (FR901228), effect on multiple myeloma

S. Alkan, T. Maududi, K. Barton, 2004, British journal of haematology.

Management of diffuse low-grade cerebral gliomas.

M. Primeau, V. Prabhu, John M. Lee, 2010, Neurologic clinics.

Expression of the IFN alpha receptor in hairy cell leukaemia.

L. Platanias, L. Pfeffer, J. Vardiman, 1992, British journal of haematology.

Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease.

L. Garrett-Sinha, J. Clements, D. Percy, 2005, International immunology.

Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial

Scott E. Smith, S. Alkan, K. Rychlik, 2008, Leukemia & lymphoma.

Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.

J. Friedberg, R. Fisher, T. Miller, 2015, Blood.

Expression Pattern of the Ets-related Transcription Factor Elf-1

A. Bassuk, M. Lu, J. Leiden, 1998, Molecular medicine.

SYNERGISTIC THERAPIES FOR RECURRENT MALIGNANT GLIOMAS.

V. Prabhu, E. Piedras-Rentería, E. Melian, 2019, World neurosurgery.

Cardiac Effects of Bortezomib Therapy in a Case of AL Amyloidosis Presenting with Bradycardia and Heart Failure

Nader Makki, Taishi Hirai, K. Barton, 2014 .

from Multiple Myeloma Patients and Cell Lines

H. Avet-Loiseau, L. Coignet, S. Alkan, 2016 .

Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge

S. Nand, K. Barton, 2007, Leukemia & lymphoma.

The role of the Exon 13 G571S JAK2 mutation in myeloproliferative neoplasms

A. Kini, K. Barton, B. Bahar, 2016, Leukemia research reports.

Delayed leptomeningeal metastasis of an adult anaplastic pilocytic astrocytoma

J. Leonetti, E. Melian, R. Lukas, 2018, Brain Tumor Pathology.

Precursor B-cell acute lymphoblastic leukaemia with FAB L3 (i.e., Burkitt's leukaemia/lymphoma) morphology and co-expression of monoclonal surface light chains and Tdt: report of a unique case and review of the literature.

S. Alkan, K. Barton, M. Velankar, 2009, Pathology.

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Scott E. Smith, P. Stiff, S. Nand, 2009 .